PMDD is treatable, and most people find significant relief with the right combination of medication, therapy, or lifestyle changes. The first-line options, particularly SSRIs and specific oral contraceptives, work well for the majority of people with PMDD. For those who don’t respond to initial treatments, there’s a clear ladder of increasingly targeted options, up to and including surgical approaches for the most severe cases.
SSRIs: The Most Effective First-Line Treatment
Selective serotonin reuptake inhibitors are the best-studied and most widely recommended treatment for PMDD. Fluoxetine and sertraline are the two with FDA approval specifically for this condition. What makes SSRIs unusual in PMDD treatment is how fast they work. Unlike depression, where SSRIs can take weeks to kick in, they improve PMDD symptoms rapidly, often within the first cycle.
This fast response opens up an option that many people find appealing: luteal-phase dosing. Instead of taking medication every day, you only take it during the roughly two weeks between ovulation and your period, then stop when bleeding starts. This cuts your total medication exposure by half or more. In clinical trials of sertraline using this approach, three out of four people reported no side effects at all, and the rest experienced only mild, temporary ones. You can even start at the onset of symptoms rather than at ovulation and still see benefits.
Continuous daily dosing is better suited if your symptoms are unpredictable in timing, or if you also have depression or an anxiety disorder alongside PMDD. Starting doses are typically low (fluoxetine at 10 mg, sertraline at 25 mg), and many people do well without needing to increase. For sertraline, evidence suggests that 25 mg works as well as 50 mg for PMDD specifically.
Hormonal Options: Oral Contraceptives
One specific oral contraceptive formulation has FDA approval for PMDD: a pill containing drospirenone and ethinyl estradiol, sold as Yaz and its generics. It uses a 24/4 schedule (24 active pills and 4 inactive pills per pack), which is different from the traditional 21/7 format and helps minimize the hormone-free window that can trigger symptoms.
In clinical trials, people on this pill saw a 37.5-point improvement in symptom severity scores compared to 30 points on placebo. That’s a real but moderate advantage. The most common side effects include spotting (about 25% of users), nausea (16%), headache (13%), and breast tenderness (11%). This option makes the most sense if you also want contraception, since the pill serves both purposes at once.
Cognitive Behavioral Therapy
CBT is recommended for moderate to severe PMDD, particularly for the emotional and mood-related symptoms. A typical course involves 8 to 12 weekly sessions, each lasting about 90 minutes, spread over roughly three months. The work focuses on identifying the negative thought patterns that intensify during the premenstrual phase and building specific skills to interrupt them.
Practical techniques include recognizing automatic thoughts (the harsh self-critical scripts that ramp up before your period), challenging cognitive distortions like catastrophizing or emotional reasoning, relaxation and controlled breathing exercises, assertiveness training, and anger management strategies. CBT doesn’t change the hormonal trigger, but it changes how your brain responds to it. It’s useful on its own for people who prefer non-pharmaceutical approaches, or as an add-on to medication for people who need more complete relief.
Supplements With Clinical Support
Calcium is the best-studied supplement for premenstrual symptoms. Doses of 500 mg to 1,200 mg daily have reduced depression, fatigue, bloating, and pain in controlled trials. A large placebo-controlled study found significant improvement at 1,200 mg per day. Lower doses of 500 mg daily over two months also showed benefits, so you don’t necessarily need the highest dose to see results.
Vitamin B6 has evidence supporting its use at 80 mg daily, with one controlled trial showing reductions in moodiness, irritability, anxiety, bloating, and forgetfulness over three menstrual cycles. The safe upper limit set by the U.S. is 100 mg per day. The European Food Safety Authority is more conservative, placing it at 12 mg per day. Long-term intake of very high doses (1,000 mg or more daily) can cause nerve damage with loss of coordination and sensation, so staying well under 100 mg is important if you use this supplement.
Dietary and Lifestyle Adjustments
The American Congress of Obstetrics and Gynecology recommends that people with premenstrual symptoms avoid caffeine entirely, especially if breast tenderness is a prominent symptom. Caffeine blocks a calming brain chemical called adenosine and narrows blood vessels, both of which can amplify the irritability, anxiety, and physical discomfort of PMDD. It also appears to shift hormone levels during the luteal phase in ways that may worsen symptoms.
Regular aerobic exercise is consistently associated with reduced PMDD severity, likely through its effects on mood-regulating brain chemicals and stress hormones. Even moderate activity like brisk walking helps. Reducing alcohol and highly processed sugar during the luteal phase is commonly recommended as well, though the evidence for sugar is less mechanistically clear than for caffeine.
GnRH Agonists for Treatment-Resistant Cases
When SSRIs, oral contraceptives, and other front-line approaches haven’t provided enough relief, a class of medications called GnRH agonists can temporarily shut down ovarian hormone production, essentially creating a reversible, temporary menopause. This eliminates the hormonal cycling that drives PMDD symptoms.
Because this artificial menopause carries risks to bone density and causes symptoms like hot flashes, it’s paired with low-dose “add-back” hormones to protect your bones and manage side effects. The key distinction from regular hormone cycling is that add-back therapy provides steady, non-fluctuating hormone levels, which avoids retriggering PMDD. This treatment is reserved for people who’ve genuinely tried and failed the first- and second-line options.
Surgery as a Last Resort
For the most severe, treatment-resistant cases, removal of both ovaries (bilateral oophorectomy) permanently eliminates the hormonal cycle causing PMDD. This is irreversible and causes immediate surgical menopause, so it’s held as a final option. Before most surgeons will consider it, you’ll typically need to document that you’ve tried SSRIs, drospirenone-containing oral contraceptives, and other evidence-based treatments without adequate relief. Any co-occurring conditions like major depression or generalized anxiety need to be addressed separately first.
Most doctors also require a trial of GnRH agonists beforehand, essentially a temporary “test run” of menopause. If your PMDD symptoms resolve or dramatically improve during that trial, it’s a strong signal that surgery will be effective. If symptoms persist even with ovarian suppression, surgery is unlikely to help and the underlying issue may be something other than PMDD.
Building a Treatment Plan
PMDD treatment works best when it’s layered and personalized. Many people start with lifestyle changes and supplements, add an SSRI (often with luteal-phase dosing for convenience and fewer side effects), and use CBT to develop long-term coping strategies. If that combination isn’t enough, hormonal treatments and eventually GnRH agonists provide progressively stronger intervention. Tracking your symptoms daily across at least two full cycles is essential both for confirming the diagnosis and for measuring whether a given treatment is actually working. The DSM-5 requires at least five symptoms present in the final week before your period, including at least one core mood symptom like marked irritability, depressed mood, anxiety, or mood swings, that improve within a few days of bleeding and resolve in the week after.
The pattern matters as much as the symptoms themselves. If your symptoms don’t clearly follow the cycle of worsening before your period and improving after, the issue may be a different mood disorder that happens to feel worse premenstrually, and the treatment approach would be different.